Early Changes in Protein Expression Detected by Mass Spectrometry Predict Tumor Response to Molecular Therapeutics
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Biomarkers that predict therapeutic response are essential for the development of anticancer therapies. We have used matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) to directly analyze protein profiles in mouse mammary tumor virus/HER2 transgenic mouse frozen tumor sections after treatment with the erbB receptor inhibitors OSI-774 and Herceptin. Inhibition of tumor cell proliferation and induction of apoptosis and tumor reduction were predicted by a >80% reduction in thymosin β4 and ubiquitin levels that were detectable after 16 hours of a single drug dose before any evidence of in situ cellular activity. These effects were time- and dose-dependent, and their spatial distribution in the tumor correlated with that of the small-molecule inhibitor OSI-774. In addition, they predicted for therapeutic synergy of OSI-774 and Herceptin as well as for drug resistance. These results suggest that drug-induced early proteomic changes as measured by MALDI-MS can be used to predict the therapeutic response to established and novel therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidalgo, M., Siu, L. L., Nemunaitis, J., Rizzo, J., Hammond, L. A., Takimoto, C., Eckhardt, S. G., Tolcher, A., Britten, C. D., Denis, L., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3267 · Cited by 1,001
Finkle, D., Quan, Z. R., Asghari, V., Kloss, J., Ghaboosi, N., Mai, E., Wong, W. L., Hollingshead, P., Schwall, R., Koeppen, H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0448 · Cited by 125 · cited 2×
“We first determined the efficacy of signaling inhibitors against tumors arising in MMTV/HER2 transgenic mice (10).”
Background
Cited by
MALDI imaging mass spectrometry: molecular snapshots of biochemical systems
Cornett, D. S., Reyzer, M. L., Chaurand, P., & Caprioli, R. M. (2007) · Nature Methods · doi:10.1038/nmeth1094 · Cited by 886
Self-citationMolecular imaging by mass spectrometry — looking beyond classical histology
Schwamborn, K., & Caprioli, R. M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2917 · Cited by 354
Self-citationMALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology
Walch, A., Rauser, S., Deininger, S.-O., & Höfler, H. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0469-9 · Cited by 334
Molecular imaging of proteins in tissues by mass spectrometry
Seeley, E. H., & Caprioli, R. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801374105 · Cited by 303
Self-citationSeeley, E. H., Oppenheimer, S. R., Mi, D., Chaurand, P., & Caprioli, R. M. (2008) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2008.03.016 · Cited by 300
Self-citation
Metadata
- Authors
- Reyzer, M. L., Caldwell, R. L., Dugger, T. C., Forbes, J. T., Ritter, C. A., Guix, M., Arteaga, C. L., & Caprioli, R. M.
- Venue
- Cancer Research
- Published
- 2004-12-15
- Volume
- 64
- Issue
- 24
- Pages
- 9093-9100
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2134171575
- Cited by
- 154
- References
- 2
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early Changes in Protein Expression Detected by Mass Spectrometry Predict Tumor Response to Molecular Therapeutics. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-2231
- The paper
- Reyzer, M. L., Caldwell, R. L., Dugger, T. C., Forbes, J. T., Ritter, C. A., Guix, M., Arteaga, C. L., & Caprioli, R. M. (2004). Early Changes in Protein Expression Detected by Mass Spectrometry Predict Tumor Response to Molecular Therapeutics. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-2231
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.